Amikacin pharmacokinetics in pediatric patients with malignancy.

The pharmacokinetics of amikacin were evaluated in 50 pediatric patients (1 to 17 years of age) with malignancies and normal renal function. Dosage regimens of 5 mg/kg per dose were administered intravenously (i) over 30 min every 8 h, (ii) over 60 min every 8 h, and (iii) over 60 min every 6 h. Adm...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Cleary, T G, Pickering, L K, Kramer, W G, Culbert, S, Frankel, L S, Kohl, S
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1979
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC352961/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/533263/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.16.6.829
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!